Trial intelligence / Profile preview

Single-dose versus triple-dose mebendazole for hookworm infection in school children

PACTR201911466695052Completed

Sponsor
University of Gondar
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of mebendazole in hookworm infection (2 arms), sponsored by University of Gondar. Primary endpoint: Cure rate. Started Apr 2019; status: completed.

02

Drugs

mebendazole
03

Conditions

hookworm infection

Beyond the preview

Go deeper on PACTR201911466695052.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201911466695052.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call